Author:
Schillie Sarah,Harris Aaron,Link-Gelles Ruth,Romero José,Ward John,Nelson Noele
Publisher
Centers for Disease Control MMWR Office
Subject
Health Information Management,Health, Toxicology and Mutagenesis,General Medicine,Health (social science),Epidemiology
Reference11 articles.
1. Food and Drug Administration. Product approval information: package insert. Heplisav-B. Silver Spring, MD: US Department of Health and Human Services, Food and Drug Administration; 2018. https://www.fda.gov/BiologicsBloodVaccines/Vaccines/ApprovedProducts/ucm584752.htm
2. Prevention of hepatitis B virus infection in the United States: recommendations of the Advisory Committee on Immunization Practices.;CDC;MMWR Recomm Rep,2018
3. New framework (GRADE) for development of evidence-based recommendations by the Advisory Committee on Immunization Practices.;CDC;MMWR Morb Mortal Wkly Rep,2012
4. Comparison of the safety and immunogenicity of hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide and a licensed hepatitis B vaccine in healthy young adults.;Halperin;Vaccine,2006
5. Comparison of safety and immunogenicity of two doses of investigational hepatitis B virus surface antigen co-administered with an immunostimulatory phosphorothioate oligodeoxyribonucleotide and three doses of a licensed hepatitis B vaccine in healthy adults 18–55 years of age.;Halperin;Vaccine,2012
Cited by
147 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献